FAG
TAK icon

Fortitude Advisory Group’s Takeda Pharmaceutical TAK Stock Holding History

Fortitude Advisory Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-230
Closed -$3K – 1154
2022
Q1 		$3K Hold
230
– – ﹤0.01% 1289
2021
Q4 		$3K Buy
+230
New +$3.23K ﹤0.01% 1323

Other funds holding TAK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fortitude Advisory Group's TAK Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 230 shares — an estimated $3K sold.

Fortitude Advisory Group first reported a position in TAK in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 230 Takeda Pharmaceutical shares in Q2 2022, an estimated $3K.
  • Fortitude Advisory Group first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's Takeda Pharmaceutical position peaked at $3K in Q1 2022.
  • 283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.